Kidney removal after immunotherapy may offer cure for select patients

NCT ID NCT06882486

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether removing the kidney after successful immunotherapy can help patients with metastatic kidney cancer stop all treatment and stay cancer-free. About 60 adults whose tumors have shrunk significantly with immunotherapy will either have surgery and stop therapy, or continue therapy without surgery. The goal is to see if this approach can lead to long-term remission and potentially a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Paoli-Calmettes

    RECRUITING

    Marseille, Institut Paoli-calmettes, 13273, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.